newsroompost
  • youtube
  • facebook
  • twitter

These 55 countries to get India’s anti-malarial drug HCQ for combating Covid-19

Modi govt has decided to donate these drugs to SAARC nations, countries in Africa and Latin America. Here the amount would be in smaller countries, unlike commercial sale to US & European countries.

Hydroxychloroquine and Azithromycin in COVID 19 should be immediately approved for COVID treatment

New Delhi: As the Coronavirus cases keep mounting across the world, all eyes are on India’s life-saving drug Hydroxychloroquine (HCQ) which has apparently been used in treating Covid-19 patients.

Many countries have sought the supply of this ‘wonder drug’ from India, so that lives could be saved.

Hydroxychloroquine and Azithromycin in COVID 19 should be immediately approved for COVID treatment

India has agreed to export the anti-malarial drug HCQ to 55 countries, top govt sources said.

According to sources, India will be exporting these drugs to US, Brazil, Spain, Germany, Bahrain, Nepal, Bhutan, Afghanistan, Maldives, Bangladesh, Seychelles, Mauritius, Dominican Republic, Israel, Canada, UK, France, Australia, New Zealand and some other African countries, including South Africa.

While the above governments will get the drug on commercial basis, the Modi govt has decided to donate these drugs to SAARC nations, countries in Africa and Latin America. Here the amount would be in smaller countries, unlike commercial sale to US & European countries.